Skip to main content

Table 2 Participant quality of life, disability scores and serology

From: The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients

  HC ME/CFS P-value
SF-36 (%)
 Physical functioning 96.33 ± 2.89 44.00 ± 7.24  < 0.001
 Physical role 93.33 ± 2.89 28.33 ± 6.87  < 0.001
 Pain 89.33 ± 3.022 42.833 ± 6.70  < 0.001
 General health 79.43 ± 3.48 34.71 ± 4.64  < 0.001
 Social functioning 94.16 ± 2.95 34.17 ± 6.03  < 0.001
 Emotional role 93.33 ± 3.02 70.00 ± 6.44 0.007
 Emotional wellbeing 74.07 ± 4.48 43.82 ± 3.92  < 0.001
WHO DAS (%)
 Communication & understanding 7.19 ± 1.96 40.81 ± 4.49  < 0.001
 Mobility 2.67 ± 0.83 40.67 ± 7.44  < 0.001
 Self-care 0 ± 0 20.41 ± 5.37 0.004
 Interpersonal relationships 7.92 ± 2.69 32.91 ± 4.97  < 0.001
 Life activities 6.67 ± 2.23 56.25 ± 8.09  < 0.001
 Participation in society 3.12 ± 1.55 50.62 ± 5.86  < 0.001
Full blood count
 White cell count (× 109/L) 5.40 ± 0.32 6.07 ± 0.48 0.262
 Lymphocytes (× 109/L) 1.76 ± 0.15 1.88 ± 0.11 0.517
 Neutrophils (× 109/L) 3.07 ± 0.26 3.51 ± 0.38 0.345
 Monocytes (× 109/L) 0.40 ± 0.03 0.43 ± 0.04 0.598
 Eosinophils (× 109/L) 0.12 ± 0.02 0.18 ± 0.02 0.033
 Basophils (× 109/L) 0.04 ± 0.01 0.04 ± 0.004 0.631
 Platelets (× 109/L) 239.67 ± 14.59 254.20 ± 11.10 0.435
 Red Cell Count (× 1012/L) 4.82 ± 0.13 4.67 ± 0.10 0.356
 Haematocrit 0.43 ± 0.01 0.42 ± 0.01 0.806
 Haemoglobin (g/L) 143.07 ± 4.10 141.0 ± 2.76 0.680
  1. Values in bold indicate statistical significance
  2. HC healthy controls, ME Myalgic encephalomyelitis, CFS chronic fatigue syndrome, SF-36 36-item short form survey, WHO world health organization, DAS disability assessment schedule